Cargando…
Refining the use of neoadjuvant chemotherapy in locally advanced bladder cancer: from conviction to optimization
Autores principales: | Culine, Stéphane, Allory, Yves, Pfister, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127548/ https://www.ncbi.nlm.nih.gov/pubmed/30211071 http://dx.doi.org/10.21037/tau.2018.06.11 |
Ejemplares similares
-
Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial
por: Pfister, Christian, et al.
Publicado: (2020) -
Refining the Characterization and Outcome of Pathological Complete Responders after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Lessons from the Randomized Phase III VESPER (GETUG-AFU V05) Trial
por: Culine, Stéphane, et al.
Publicado: (2023) -
Another Conviction for Substitution
Publicado: (1905) -
Medical Service for Convicts
Publicado: (1886) -
“Alba” Dentists Convicted
Publicado: (1903)